Pharma & Healthcare
Global Plasma Fractionation and Blood Product Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4210
- Pages: 106
- Figures: 135
- Views: 19
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
The global Plasma Fractionation and Blood Product market is projected to grow from US$ 4935.7 million in 2024 to US$ 5825.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.8% during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Plasma Fractionation and Blood Product, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Plasma Fractionation and Blood Product, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Plasma Fractionation and Blood Product, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plasma Fractionation and Blood Product sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Plasma Fractionation and Blood Product market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Plasma Fractionation and Blood Product sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Segment by Type
Coagulation Factor
Immune Globulin
Albumin
Other
Segment by Application
Immunology
Hematology
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Plasma Fractionation and Blood Product in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Plasma Fractionation and Blood Product manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Fractionation and Blood Product sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Plasma Fractionation and Blood Product market is projected to grow from US$ 4935.7 million in 2024 to US$ 5825.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.8% during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Plasma Fractionation and Blood Product, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Plasma Fractionation and Blood Product, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Plasma Fractionation and Blood Product, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plasma Fractionation and Blood Product sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Plasma Fractionation and Blood Product market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Plasma Fractionation and Blood Product sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Segment by Type
Coagulation Factor
Immune Globulin
Albumin
Other
Segment by Application
Immunology
Hematology
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Plasma Fractionation and Blood Product in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Plasma Fractionation and Blood Product manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Fractionation and Blood Product sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Plasma Fractionation and Blood Product Product Introduction
1.2 Market by Type
1.2.1 Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Plasma Fractionation and Blood Product Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Immunology
1.3.3 Hematology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Plasma Fractionation and Blood Product Sales Estimates and Forecasts 2019-2030
2.2 Global Plasma Fractionation and Blood Product Revenue by Region
2.2.1 Global Plasma Fractionation and Blood Product Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Plasma Fractionation and Blood Product Revenue by Region (2019-2024)
2.2.3 Global Plasma Fractionation and Blood Product Revenue by Region (2025-2030)
2.2.4 Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2019-2030)
2.3 Global Plasma Fractionation and Blood Product Sales Estimates and Forecasts 2019-2030
2.4 Global Plasma Fractionation and Blood Product Sales by Region
2.4.1 Global Plasma Fractionation and Blood Product Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Plasma Fractionation and Blood Product Sales by Region (2019-2024)
2.4.3 Global Plasma Fractionation and Blood Product Sales by Region (2025-2030)
2.4.4 Global Plasma Fractionation and Blood Product Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Plasma Fractionation and Blood Product Sales by Manufacturers
3.1.1 Global Plasma Fractionation and Blood Product Sales by Manufacturers (2019-2024)
3.1.2 Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma Fractionation and Blood Product in 2023
3.2 Global Plasma Fractionation and Blood Product Revenue by Manufacturers
3.2.1 Global Plasma Fractionation and Blood Product Revenue by Manufacturers (2019-2024)
3.2.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Plasma Fractionation and Blood Product Revenue in 2023
3.3 Global Key Players of Plasma Fractionation and Blood Product, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Plasma Fractionation and Blood Product Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Plasma Fractionation and Blood Product, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Plasma Fractionation and Blood Product, Product Offered and Application
3.8 Global Key Manufacturers of Plasma Fractionation and Blood Product, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Plasma Fractionation and Blood Product Sales by Type
4.1.1 Global Plasma Fractionation and Blood Product Historical Sales by Type (2019-2024)
4.1.2 Global Plasma Fractionation and Blood Product Forecasted Sales by Type (2025-2030)
4.1.3 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
4.2 Global Plasma Fractionation and Blood Product Revenue by Type
4.2.1 Global Plasma Fractionation and Blood Product Historical Revenue by Type (2019-2024)
4.2.2 Global Plasma Fractionation and Blood Product Forecasted Revenue by Type (2025-2030)
4.2.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
4.3 Global Plasma Fractionation and Blood Product Price by Type
4.3.1 Global Plasma Fractionation and Blood Product Price by Type (2019-2024)
4.3.2 Global Plasma Fractionation and Blood Product Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Plasma Fractionation and Blood Product Sales by Application
5.1.1 Global Plasma Fractionation and Blood Product Historical Sales by Application (2019-2024)
5.1.2 Global Plasma Fractionation and Blood Product Forecasted Sales by Application (2025-2030)
5.1.3 Global Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
5.2 Global Plasma Fractionation and Blood Product Revenue by Application
5.2.1 Global Plasma Fractionation and Blood Product Historical Revenue by Application (2019-2024)
5.2.2 Global Plasma Fractionation and Blood Product Forecasted Revenue by Application (2025-2030)
5.2.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
5.3 Global Plasma Fractionation and Blood Product Price by Application
5.3.1 Global Plasma Fractionation and Blood Product Price by Application (2019-2024)
5.3.2 Global Plasma Fractionation and Blood Product Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Plasma Fractionation and Blood Product Market Size by Type
6.1.1 US & Canada Plasma Fractionation and Blood Product Sales by Type (2019-2030)
6.1.2 US & Canada Plasma Fractionation and Blood Product Revenue by Type (2019-2030)
6.2 US & Canada Plasma Fractionation and Blood Product Market Size by Application
6.2.1 US & Canada Plasma Fractionation and Blood Product Sales by Application (2019-2030)
6.2.2 US & Canada Plasma Fractionation and Blood Product Revenue by Application (2019-2030)
6.3 US & Canada Plasma Fractionation and Blood Product Market Size by Country
6.3.1 US & Canada Plasma Fractionation and Blood Product Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Plasma Fractionation and Blood Product Sales by Country (2019-2030)
6.3.3 US & Canada Plasma Fractionation and Blood Product Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Plasma Fractionation and Blood Product Market Size by Type
7.1.1 Europe Plasma Fractionation and Blood Product Sales by Type (2019-2030)
7.1.2 Europe Plasma Fractionation and Blood Product Revenue by Type (2019-2030)
7.2 Europe Plasma Fractionation and Blood Product Market Size by Application
7.2.1 Europe Plasma Fractionation and Blood Product Sales by Application (2019-2030)
7.2.2 Europe Plasma Fractionation and Blood Product Revenue by Application (2019-2030)
7.3 Europe Plasma Fractionation and Blood Product Market Size by Country
7.3.1 Europe Plasma Fractionation and Blood Product Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Plasma Fractionation and Blood Product Sales by Country (2019-2030)
7.3.3 Europe Plasma Fractionation and Blood Product Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Plasma Fractionation and Blood Product Market Size
8.1.1 China Plasma Fractionation and Blood Product Sales (2019-2030)
8.1.2 China Plasma Fractionation and Blood Product Revenue (2019-2030)
8.2 China Plasma Fractionation and Blood Product Market Size by Application
8.2.1 China Plasma Fractionation and Blood Product Sales by Application (2019-2030)
8.2.2 China Plasma Fractionation and Blood Product Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Plasma Fractionation and Blood Product Market Size by Type
9.1.1 Asia Plasma Fractionation and Blood Product Sales by Type (2019-2030)
9.1.2 Asia Plasma Fractionation and Blood Product Revenue by Type (2019-2030)
9.2 Asia Plasma Fractionation and Blood Product Market Size by Application
9.2.1 Asia Plasma Fractionation and Blood Product Sales by Application (2019-2030)
9.2.2 Asia Plasma Fractionation and Blood Product Revenue by Application (2019-2030)
9.3 Asia Plasma Fractionation and Blood Product Sales by Region
9.3.1 Asia Plasma Fractionation and Blood Product Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Plasma Fractionation and Blood Product Revenue by Region (2019-2030)
9.3.3 Asia Plasma Fractionation and Blood Product Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Market Size by Type
10.1.1 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Market Size by Application
10.2.1 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Country
10.3.1 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Takeda Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 CSL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Grifols Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Octapharma Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Kedrion
11.5.1 Kedrion Company Information
11.5.2 Kedrion Overview
11.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Kedrion Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kedrion Recent Developments
11.6 LFB Group
11.6.1 LFB Group Company Information
11.6.2 LFB Group Overview
11.6.3 LFB Group Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 LFB Group Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 LFB Group Recent Developments
11.7 Biotest
11.7.1 Biotest Company Information
11.7.2 Biotest Overview
11.7.3 Biotest Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Biotest Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biotest Recent Developments
11.8 BPL
11.8.1 BPL Company Information
11.8.2 BPL Overview
11.8.3 BPL Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 BPL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BPL Recent Developments
11.9 RAAS
11.9.1 RAAS Company Information
11.9.2 RAAS Overview
11.9.3 RAAS Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 RAAS Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Company Information
11.10.2 CBPO Overview
11.10.3 CBPO Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 CBPO Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CBPO Recent Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Company Information
11.11.2 Hualan Bio Overview
11.11.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Hualan Bio Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hualan Bio Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Plasma Fractionation and Blood Product Industry Chain Analysis
12.2 Plasma Fractionation and Blood Product Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plasma Fractionation and Blood Product Production Mode & Process
12.4 Plasma Fractionation and Blood Product Sales and Marketing
12.4.1 Plasma Fractionation and Blood Product Sales Channels
12.4.2 Plasma Fractionation and Blood Product Distributors
12.5 Plasma Fractionation and Blood Product Customers
13 Market Dynamics
13.1 Plasma Fractionation and Blood Product Industry Trends
13.2 Plasma Fractionation and Blood Product Market Drivers
13.3 Plasma Fractionation and Blood Product Market Challenges
13.4 Plasma Fractionation and Blood Product Market Restraints
14 Key Findings in The Global Plasma Fractionation and Blood Product Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Plasma Fractionation and Blood Product Product Introduction
1.2 Market by Type
1.2.1 Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Plasma Fractionation and Blood Product Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Immunology
1.3.3 Hematology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Plasma Fractionation and Blood Product Sales Estimates and Forecasts 2019-2030
2.2 Global Plasma Fractionation and Blood Product Revenue by Region
2.2.1 Global Plasma Fractionation and Blood Product Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Plasma Fractionation and Blood Product Revenue by Region (2019-2024)
2.2.3 Global Plasma Fractionation and Blood Product Revenue by Region (2025-2030)
2.2.4 Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2019-2030)
2.3 Global Plasma Fractionation and Blood Product Sales Estimates and Forecasts 2019-2030
2.4 Global Plasma Fractionation and Blood Product Sales by Region
2.4.1 Global Plasma Fractionation and Blood Product Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Plasma Fractionation and Blood Product Sales by Region (2019-2024)
2.4.3 Global Plasma Fractionation and Blood Product Sales by Region (2025-2030)
2.4.4 Global Plasma Fractionation and Blood Product Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Plasma Fractionation and Blood Product Sales by Manufacturers
3.1.1 Global Plasma Fractionation and Blood Product Sales by Manufacturers (2019-2024)
3.1.2 Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma Fractionation and Blood Product in 2023
3.2 Global Plasma Fractionation and Blood Product Revenue by Manufacturers
3.2.1 Global Plasma Fractionation and Blood Product Revenue by Manufacturers (2019-2024)
3.2.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Plasma Fractionation and Blood Product Revenue in 2023
3.3 Global Key Players of Plasma Fractionation and Blood Product, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Plasma Fractionation and Blood Product Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Plasma Fractionation and Blood Product, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Plasma Fractionation and Blood Product, Product Offered and Application
3.8 Global Key Manufacturers of Plasma Fractionation and Blood Product, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Plasma Fractionation and Blood Product Sales by Type
4.1.1 Global Plasma Fractionation and Blood Product Historical Sales by Type (2019-2024)
4.1.2 Global Plasma Fractionation and Blood Product Forecasted Sales by Type (2025-2030)
4.1.3 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
4.2 Global Plasma Fractionation and Blood Product Revenue by Type
4.2.1 Global Plasma Fractionation and Blood Product Historical Revenue by Type (2019-2024)
4.2.2 Global Plasma Fractionation and Blood Product Forecasted Revenue by Type (2025-2030)
4.2.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
4.3 Global Plasma Fractionation and Blood Product Price by Type
4.3.1 Global Plasma Fractionation and Blood Product Price by Type (2019-2024)
4.3.2 Global Plasma Fractionation and Blood Product Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Plasma Fractionation and Blood Product Sales by Application
5.1.1 Global Plasma Fractionation and Blood Product Historical Sales by Application (2019-2024)
5.1.2 Global Plasma Fractionation and Blood Product Forecasted Sales by Application (2025-2030)
5.1.3 Global Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
5.2 Global Plasma Fractionation and Blood Product Revenue by Application
5.2.1 Global Plasma Fractionation and Blood Product Historical Revenue by Application (2019-2024)
5.2.2 Global Plasma Fractionation and Blood Product Forecasted Revenue by Application (2025-2030)
5.2.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
5.3 Global Plasma Fractionation and Blood Product Price by Application
5.3.1 Global Plasma Fractionation and Blood Product Price by Application (2019-2024)
5.3.2 Global Plasma Fractionation and Blood Product Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Plasma Fractionation and Blood Product Market Size by Type
6.1.1 US & Canada Plasma Fractionation and Blood Product Sales by Type (2019-2030)
6.1.2 US & Canada Plasma Fractionation and Blood Product Revenue by Type (2019-2030)
6.2 US & Canada Plasma Fractionation and Blood Product Market Size by Application
6.2.1 US & Canada Plasma Fractionation and Blood Product Sales by Application (2019-2030)
6.2.2 US & Canada Plasma Fractionation and Blood Product Revenue by Application (2019-2030)
6.3 US & Canada Plasma Fractionation and Blood Product Market Size by Country
6.3.1 US & Canada Plasma Fractionation and Blood Product Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Plasma Fractionation and Blood Product Sales by Country (2019-2030)
6.3.3 US & Canada Plasma Fractionation and Blood Product Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Plasma Fractionation and Blood Product Market Size by Type
7.1.1 Europe Plasma Fractionation and Blood Product Sales by Type (2019-2030)
7.1.2 Europe Plasma Fractionation and Blood Product Revenue by Type (2019-2030)
7.2 Europe Plasma Fractionation and Blood Product Market Size by Application
7.2.1 Europe Plasma Fractionation and Blood Product Sales by Application (2019-2030)
7.2.2 Europe Plasma Fractionation and Blood Product Revenue by Application (2019-2030)
7.3 Europe Plasma Fractionation and Blood Product Market Size by Country
7.3.1 Europe Plasma Fractionation and Blood Product Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Plasma Fractionation and Blood Product Sales by Country (2019-2030)
7.3.3 Europe Plasma Fractionation and Blood Product Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Plasma Fractionation and Blood Product Market Size
8.1.1 China Plasma Fractionation and Blood Product Sales (2019-2030)
8.1.2 China Plasma Fractionation and Blood Product Revenue (2019-2030)
8.2 China Plasma Fractionation and Blood Product Market Size by Application
8.2.1 China Plasma Fractionation and Blood Product Sales by Application (2019-2030)
8.2.2 China Plasma Fractionation and Blood Product Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Plasma Fractionation and Blood Product Market Size by Type
9.1.1 Asia Plasma Fractionation and Blood Product Sales by Type (2019-2030)
9.1.2 Asia Plasma Fractionation and Blood Product Revenue by Type (2019-2030)
9.2 Asia Plasma Fractionation and Blood Product Market Size by Application
9.2.1 Asia Plasma Fractionation and Blood Product Sales by Application (2019-2030)
9.2.2 Asia Plasma Fractionation and Blood Product Revenue by Application (2019-2030)
9.3 Asia Plasma Fractionation and Blood Product Sales by Region
9.3.1 Asia Plasma Fractionation and Blood Product Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Plasma Fractionation and Blood Product Revenue by Region (2019-2030)
9.3.3 Asia Plasma Fractionation and Blood Product Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Market Size by Type
10.1.1 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Market Size by Application
10.2.1 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Country
10.3.1 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Takeda Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 CSL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Grifols Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Octapharma Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Kedrion
11.5.1 Kedrion Company Information
11.5.2 Kedrion Overview
11.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Kedrion Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kedrion Recent Developments
11.6 LFB Group
11.6.1 LFB Group Company Information
11.6.2 LFB Group Overview
11.6.3 LFB Group Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 LFB Group Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 LFB Group Recent Developments
11.7 Biotest
11.7.1 Biotest Company Information
11.7.2 Biotest Overview
11.7.3 Biotest Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Biotest Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biotest Recent Developments
11.8 BPL
11.8.1 BPL Company Information
11.8.2 BPL Overview
11.8.3 BPL Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 BPL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BPL Recent Developments
11.9 RAAS
11.9.1 RAAS Company Information
11.9.2 RAAS Overview
11.9.3 RAAS Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 RAAS Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Company Information
11.10.2 CBPO Overview
11.10.3 CBPO Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 CBPO Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CBPO Recent Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Company Information
11.11.2 Hualan Bio Overview
11.11.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Hualan Bio Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hualan Bio Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Plasma Fractionation and Blood Product Industry Chain Analysis
12.2 Plasma Fractionation and Blood Product Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plasma Fractionation and Blood Product Production Mode & Process
12.4 Plasma Fractionation and Blood Product Sales and Marketing
12.4.1 Plasma Fractionation and Blood Product Sales Channels
12.4.2 Plasma Fractionation and Blood Product Distributors
12.5 Plasma Fractionation and Blood Product Customers
13 Market Dynamics
13.1 Plasma Fractionation and Blood Product Industry Trends
13.2 Plasma Fractionation and Blood Product Market Drivers
13.3 Plasma Fractionation and Blood Product Market Challenges
13.4 Plasma Fractionation and Blood Product Market Restraints
14 Key Findings in The Global Plasma Fractionation and Blood Product Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Coagulation Factor
Table 3. Major Manufacturers of Immune Globulin
Table 4. Major Manufacturers of Albumin
Table 5. Major Manufacturers of Other
Table 6. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Plasma Fractionation and Blood Product Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Plasma Fractionation and Blood Product Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Plasma Fractionation and Blood Product Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2019-2024)
Table 11. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2025-2030)
Table 12. Global Plasma Fractionation and Blood Product Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Plasma Fractionation and Blood Product Sales by Region (2019-2024) & (K Units)
Table 14. Global Plasma Fractionation and Blood Product Sales by Region (2025-2030) & (K Units)
Table 15. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2019-2024)
Table 16. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2025-2030)
Table 17. Global Plasma Fractionation and Blood Product Sales by Manufacturers (2019-2024) & (K Units)
Table 18. Global Plasma Fractionation and Blood Product Sales Share by Manufacturers (2019-2024)
Table 19. Global Plasma Fractionation and Blood Product Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2019-2024)
Table 21. Global Key Players of Plasma Fractionation and Blood Product, Industry Ranking, 2022 VS 2023 VS 2024
Table 22. Plasma Fractionation and Blood Product Price by Manufacturers 2019-2024 (US$/Unit)
Table 23. Global Plasma Fractionation and Blood Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Plasma Fractionation and Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fractionation and Blood Product as of 2023)
Table 25. Global Key Manufacturers of Plasma Fractionation and Blood Product, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Plasma Fractionation and Blood Product, Product Offered and Application
Table 27. Global Key Manufacturers of Plasma Fractionation and Blood Product, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 30. Global Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 31. Global Plasma Fractionation and Blood Product Sales Share by Type (2019-2024)
Table 32. Global Plasma Fractionation and Blood Product Sales Share by Type (2025-2030)
Table 33. Global Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Plasma Fractionation and Blood Product Revenue Share by Type (2019-2024)
Table 36. Global Plasma Fractionation and Blood Product Revenue Share by Type (2025-2030)
Table 37. Plasma Fractionation and Blood Product Price by Type (2019-2024) & (US$/Unit)
Table 38. Global Plasma Fractionation and Blood Product Price Forecast by Type (2025-2030) & (US$/Unit)
Table 39. Global Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 40. Global Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 41. Global Plasma Fractionation and Blood Product Sales Share by Application (2019-2024)
Table 42. Global Plasma Fractionation and Blood Product Sales Share by Application (2025-2030)
Table 43. Global Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Plasma Fractionation and Blood Product Revenue Share by Application (2019-2024)
Table 46. Global Plasma Fractionation and Blood Product Revenue Share by Application (2025-2030)
Table 47. Plasma Fractionation and Blood Product Price by Application (2019-2024) & (US$/Unit)
Table 48. Global Plasma Fractionation and Blood Product Price Forecast by Application (2025-2030) & (US$/Unit)
Table 49. US & Canada Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 50. US & Canada Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 51. US & Canada Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 52. US & Canada Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 53. US & Canada Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 54. US & Canada Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 55. US & Canada Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 56. US & Canada Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 57. US & Canada Plasma Fractionation and Blood Product Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. US & Canada Plasma Fractionation and Blood Product Revenue by Country (2019-2024) & (US$ Million)
Table 59. US & Canada Plasma Fractionation and Blood Product Revenue by Country (2025-2030) & (US$ Million)
Table 60. US & Canada Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (K Units)
Table 61. US & Canada Plasma Fractionation and Blood Product Sales by Country (2025-2030) & (K Units)
Table 62. Europe Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 63. Europe Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 64. Europe Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 65. Europe Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 66. Europe Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 67. Europe Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 68. Europe Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 69. Europe Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 70. Europe Plasma Fractionation and Blood Product Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 71. Europe Plasma Fractionation and Blood Product Revenue by Country (2019-2024) & (US$ Million)
Table 72. Europe Plasma Fractionation and Blood Product Revenue by Country (2025-2030) & (US$ Million)
Table 73. Europe Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (K Units)
Table 74. Europe Plasma Fractionation and Blood Product Sales by Country (2025-2030) & (K Units)
Table 75. China Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 76. China Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 77. China Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 78. China Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 79. China Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 80. China Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 81. China Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 82. China Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 83. Asia Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 84. Asia Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 85. Asia Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 86. Asia Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 87. Asia Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 88. Asia Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 89. Asia Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 90. Asia Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 91. Asia Plasma Fractionation and Blood Product Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 92. Asia Plasma Fractionation and Blood Product Revenue by Region (2019-2024) & (US$ Million)
Table 93. Asia Plasma Fractionation and Blood Product Revenue by Region (2025-2030) & (US$ Million)
Table 94. Asia Plasma Fractionation and Blood Product Sales by Region (2019-2024) & (K Units)
Table 95. Asia Plasma Fractionation and Blood Product Sales by Region (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 98. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 100. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 102. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 104. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 105. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Country (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Country (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Country (2025-2030) & (K Units)
Table 109. Takeda Company Information
Table 110. Takeda Description and Major Businesses
Table 111. Takeda Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Takeda Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Takeda Recent Developments
Table 114. CSL Company Information
Table 115. CSL Description and Major Businesses
Table 116. CSL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. CSL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. CSL Recent Developments
Table 119. Grifols Company Information
Table 120. Grifols Description and Major Businesses
Table 121. Grifols Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Grifols Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Grifols Recent Developments
Table 124. Octapharma Company Information
Table 125. Octapharma Description and Major Businesses
Table 126. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Octapharma Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Octapharma Recent Developments
Table 129. Kedrion Company Information
Table 130. Kedrion Description and Major Businesses
Table 131. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Kedrion Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Kedrion Recent Developments
Table 134. LFB Group Company Information
Table 135. LFB Group Description and Major Businesses
Table 136. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. LFB Group Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. LFB Group Recent Developments
Table 139. Biotest Company Information
Table 140. Biotest Description and Major Businesses
Table 141. Biotest Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Biotest Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Biotest Recent Developments
Table 144. BPL Company Information
Table 145. BPL Description and Major Businesses
Table 146. BPL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. BPL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. BPL Recent Developments
Table 149. RAAS Company Information
Table 150. RAAS Description and Major Businesses
Table 151. RAAS Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. RAAS Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. RAAS Recent Developments
Table 154. CBPO Company Information
Table 155. CBPO Description and Major Businesses
Table 156. CBPO Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157. CBPO Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. CBPO Recent Developments
Table 159. Hualan Bio Company Information
Table 160. Hualan Bio Description and Major Businesses
Table 161. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 162. Hualan Bio Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Hualan Bio Recent Developments
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Plasma Fractionation and Blood Product Distributors List
Table 167. Plasma Fractionation and Blood Product Customers List
Table 168. Plasma Fractionation and Blood Product Market Trends
Table 169. Plasma Fractionation and Blood Product Market Drivers
Table 170. Plasma Fractionation and Blood Product Market Challenges
Table 171. Plasma Fractionation and Blood Product Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Fractionation and Blood Product Product Picture
Figure 2. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Plasma Fractionation and Blood Product Market Share by Type in 2023 & 2030
Figure 4. Coagulation Factor Product Picture
Figure 5. Immune Globulin Product Picture
Figure 6. Albumin Product Picture
Figure 7. Other Product Picture
Figure 8. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Plasma Fractionation and Blood Product Market Share by Application in 2023 & 2030
Figure 10. Immunology
Figure 11. Hematology
Figure 12. Other
Figure 13. Plasma Fractionation and Blood Product Report Years Considered
Figure 14. Global Plasma Fractionation and Blood Product Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Plasma Fractionation and Blood Product Revenue 2019-2030 (US$ Million)
Figure 16. Global Plasma Fractionation and Blood Product Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2019-2030)
Figure 18. Global Plasma Fractionation and Blood Product Sales 2019-2030 ((K Units)
Figure 19. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2019-2030)
Figure 20. US & Canada Plasma Fractionation and Blood Product Sales YoY (2019-2030) & (K Units)
Figure 21. US & Canada Plasma Fractionation and Blood Product Revenue YoY (2019-2030) & (US$ Million)
Figure 22. Europe Plasma Fractionation and Blood Product Sales YoY (2019-2030) & (K Units)
Figure 23. Europe Plasma Fractionation and Blood Product Revenue YoY (2019-2030) & (US$ Million)
Figure 24. China Plasma Fractionation and Blood Product Sales YoY (2019-2030) & (K Units)
Figure 25. China Plasma Fractionation and Blood Product Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Asia (excluding China) Plasma Fractionation and Blood Product Sales YoY (2019-2030) & (K Units)
Figure 27. Asia (excluding China) Plasma Fractionation and Blood Product Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales YoY (2019-2030) & (K Units)
Figure 29. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue YoY (2019-2030) & (US$ Million)
Figure 30. The Plasma Fractionation and Blood Product Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 31. The Top 5 and 10 Largest Manufacturers of Plasma Fractionation and Blood Product in the World: Market Share by Plasma Fractionation and Blood Product Revenue in 2023
Figure 32. Global Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 33. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 34. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 35. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 36. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 37. US & Canada Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 38. US & Canada Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 39. US & Canada Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 40. US & Canada Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 41. US & Canada Plasma Fractionation and Blood Product Revenue Share by Country (2019-2030)
Figure 42. US & Canada Plasma Fractionation and Blood Product Sales Share by Country (2019-2030)
Figure 43. U.S. Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 44. Canada Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 45. Europe Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 46. Europe Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 47. Europe Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 48. Europe Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 49. Europe Plasma Fractionation and Blood Product Revenue Share by Country (2019-2030)
Figure 50. Europe Plasma Fractionation and Blood Product Sales Share by Country (2019-2030)
Figure 51. Germany Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 52. France Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 53. U.K. Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 54. Italy Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 55. Russia Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 56. China Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 57. China Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 58. China Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 59. China Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 60. Asia Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 61. Asia Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 62. Asia Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 63. Asia Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 64. Asia Plasma Fractionation and Blood Product Revenue Share by Region (2019-2030)
Figure 65. Asia Plasma Fractionation and Blood Product Sales Share by Region (2019-2030)
Figure 66. Japan Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 67. South Korea Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 68. China Taiwan Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 69. Southeast Asia Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 70. India Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 73. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 75. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue Share by Country (2019-2030)
Figure 76. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales Share by Country (2019-2030)
Figure 77. Brazil Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 78. Mexico Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 79. Turkey Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 80. Israel Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 81. GCC Countries Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 82. Plasma Fractionation and Blood Product Value Chain
Figure 83. Plasma Fractionation and Blood Product Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Table 1. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Coagulation Factor
Table 3. Major Manufacturers of Immune Globulin
Table 4. Major Manufacturers of Albumin
Table 5. Major Manufacturers of Other
Table 6. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Plasma Fractionation and Blood Product Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Plasma Fractionation and Blood Product Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Plasma Fractionation and Blood Product Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2019-2024)
Table 11. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2025-2030)
Table 12. Global Plasma Fractionation and Blood Product Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Plasma Fractionation and Blood Product Sales by Region (2019-2024) & (K Units)
Table 14. Global Plasma Fractionation and Blood Product Sales by Region (2025-2030) & (K Units)
Table 15. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2019-2024)
Table 16. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2025-2030)
Table 17. Global Plasma Fractionation and Blood Product Sales by Manufacturers (2019-2024) & (K Units)
Table 18. Global Plasma Fractionation and Blood Product Sales Share by Manufacturers (2019-2024)
Table 19. Global Plasma Fractionation and Blood Product Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2019-2024)
Table 21. Global Key Players of Plasma Fractionation and Blood Product, Industry Ranking, 2022 VS 2023 VS 2024
Table 22. Plasma Fractionation and Blood Product Price by Manufacturers 2019-2024 (US$/Unit)
Table 23. Global Plasma Fractionation and Blood Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Plasma Fractionation and Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fractionation and Blood Product as of 2023)
Table 25. Global Key Manufacturers of Plasma Fractionation and Blood Product, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Plasma Fractionation and Blood Product, Product Offered and Application
Table 27. Global Key Manufacturers of Plasma Fractionation and Blood Product, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 30. Global Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 31. Global Plasma Fractionation and Blood Product Sales Share by Type (2019-2024)
Table 32. Global Plasma Fractionation and Blood Product Sales Share by Type (2025-2030)
Table 33. Global Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Plasma Fractionation and Blood Product Revenue Share by Type (2019-2024)
Table 36. Global Plasma Fractionation and Blood Product Revenue Share by Type (2025-2030)
Table 37. Plasma Fractionation and Blood Product Price by Type (2019-2024) & (US$/Unit)
Table 38. Global Plasma Fractionation and Blood Product Price Forecast by Type (2025-2030) & (US$/Unit)
Table 39. Global Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 40. Global Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 41. Global Plasma Fractionation and Blood Product Sales Share by Application (2019-2024)
Table 42. Global Plasma Fractionation and Blood Product Sales Share by Application (2025-2030)
Table 43. Global Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Plasma Fractionation and Blood Product Revenue Share by Application (2019-2024)
Table 46. Global Plasma Fractionation and Blood Product Revenue Share by Application (2025-2030)
Table 47. Plasma Fractionation and Blood Product Price by Application (2019-2024) & (US$/Unit)
Table 48. Global Plasma Fractionation and Blood Product Price Forecast by Application (2025-2030) & (US$/Unit)
Table 49. US & Canada Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 50. US & Canada Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 51. US & Canada Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 52. US & Canada Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 53. US & Canada Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 54. US & Canada Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 55. US & Canada Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 56. US & Canada Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 57. US & Canada Plasma Fractionation and Blood Product Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. US & Canada Plasma Fractionation and Blood Product Revenue by Country (2019-2024) & (US$ Million)
Table 59. US & Canada Plasma Fractionation and Blood Product Revenue by Country (2025-2030) & (US$ Million)
Table 60. US & Canada Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (K Units)
Table 61. US & Canada Plasma Fractionation and Blood Product Sales by Country (2025-2030) & (K Units)
Table 62. Europe Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 63. Europe Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 64. Europe Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 65. Europe Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 66. Europe Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 67. Europe Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 68. Europe Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 69. Europe Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 70. Europe Plasma Fractionation and Blood Product Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 71. Europe Plasma Fractionation and Blood Product Revenue by Country (2019-2024) & (US$ Million)
Table 72. Europe Plasma Fractionation and Blood Product Revenue by Country (2025-2030) & (US$ Million)
Table 73. Europe Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (K Units)
Table 74. Europe Plasma Fractionation and Blood Product Sales by Country (2025-2030) & (K Units)
Table 75. China Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 76. China Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 77. China Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 78. China Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 79. China Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 80. China Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 81. China Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 82. China Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 83. Asia Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 84. Asia Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 85. Asia Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 86. Asia Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 87. Asia Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 88. Asia Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 89. Asia Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 90. Asia Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 91. Asia Plasma Fractionation and Blood Product Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 92. Asia Plasma Fractionation and Blood Product Revenue by Region (2019-2024) & (US$ Million)
Table 93. Asia Plasma Fractionation and Blood Product Revenue by Region (2025-2030) & (US$ Million)
Table 94. Asia Plasma Fractionation and Blood Product Sales by Region (2019-2024) & (K Units)
Table 95. Asia Plasma Fractionation and Blood Product Sales by Region (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Type (2019-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Type (2025-2030) & (K Units)
Table 98. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Type (2019-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Type (2025-2030) & (US$ Million)
Table 100. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Application (2019-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Application (2025-2030) & (K Units)
Table 102. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Application (2019-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Application (2025-2030) & (US$ Million)
Table 104. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 105. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Country (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue by Country (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Country (2019-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales by Country (2025-2030) & (K Units)
Table 109. Takeda Company Information
Table 110. Takeda Description and Major Businesses
Table 111. Takeda Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Takeda Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Takeda Recent Developments
Table 114. CSL Company Information
Table 115. CSL Description and Major Businesses
Table 116. CSL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. CSL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. CSL Recent Developments
Table 119. Grifols Company Information
Table 120. Grifols Description and Major Businesses
Table 121. Grifols Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Grifols Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Grifols Recent Developments
Table 124. Octapharma Company Information
Table 125. Octapharma Description and Major Businesses
Table 126. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Octapharma Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Octapharma Recent Developments
Table 129. Kedrion Company Information
Table 130. Kedrion Description and Major Businesses
Table 131. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Kedrion Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Kedrion Recent Developments
Table 134. LFB Group Company Information
Table 135. LFB Group Description and Major Businesses
Table 136. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. LFB Group Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. LFB Group Recent Developments
Table 139. Biotest Company Information
Table 140. Biotest Description and Major Businesses
Table 141. Biotest Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Biotest Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Biotest Recent Developments
Table 144. BPL Company Information
Table 145. BPL Description and Major Businesses
Table 146. BPL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. BPL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. BPL Recent Developments
Table 149. RAAS Company Information
Table 150. RAAS Description and Major Businesses
Table 151. RAAS Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. RAAS Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. RAAS Recent Developments
Table 154. CBPO Company Information
Table 155. CBPO Description and Major Businesses
Table 156. CBPO Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157. CBPO Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. CBPO Recent Developments
Table 159. Hualan Bio Company Information
Table 160. Hualan Bio Description and Major Businesses
Table 161. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 162. Hualan Bio Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Hualan Bio Recent Developments
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Plasma Fractionation and Blood Product Distributors List
Table 167. Plasma Fractionation and Blood Product Customers List
Table 168. Plasma Fractionation and Blood Product Market Trends
Table 169. Plasma Fractionation and Blood Product Market Drivers
Table 170. Plasma Fractionation and Blood Product Market Challenges
Table 171. Plasma Fractionation and Blood Product Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Fractionation and Blood Product Product Picture
Figure 2. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Plasma Fractionation and Blood Product Market Share by Type in 2023 & 2030
Figure 4. Coagulation Factor Product Picture
Figure 5. Immune Globulin Product Picture
Figure 6. Albumin Product Picture
Figure 7. Other Product Picture
Figure 8. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Plasma Fractionation and Blood Product Market Share by Application in 2023 & 2030
Figure 10. Immunology
Figure 11. Hematology
Figure 12. Other
Figure 13. Plasma Fractionation and Blood Product Report Years Considered
Figure 14. Global Plasma Fractionation and Blood Product Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Plasma Fractionation and Blood Product Revenue 2019-2030 (US$ Million)
Figure 16. Global Plasma Fractionation and Blood Product Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2019-2030)
Figure 18. Global Plasma Fractionation and Blood Product Sales 2019-2030 ((K Units)
Figure 19. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2019-2030)
Figure 20. US & Canada Plasma Fractionation and Blood Product Sales YoY (2019-2030) & (K Units)
Figure 21. US & Canada Plasma Fractionation and Blood Product Revenue YoY (2019-2030) & (US$ Million)
Figure 22. Europe Plasma Fractionation and Blood Product Sales YoY (2019-2030) & (K Units)
Figure 23. Europe Plasma Fractionation and Blood Product Revenue YoY (2019-2030) & (US$ Million)
Figure 24. China Plasma Fractionation and Blood Product Sales YoY (2019-2030) & (K Units)
Figure 25. China Plasma Fractionation and Blood Product Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Asia (excluding China) Plasma Fractionation and Blood Product Sales YoY (2019-2030) & (K Units)
Figure 27. Asia (excluding China) Plasma Fractionation and Blood Product Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales YoY (2019-2030) & (K Units)
Figure 29. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue YoY (2019-2030) & (US$ Million)
Figure 30. The Plasma Fractionation and Blood Product Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 31. The Top 5 and 10 Largest Manufacturers of Plasma Fractionation and Blood Product in the World: Market Share by Plasma Fractionation and Blood Product Revenue in 2023
Figure 32. Global Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 33. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 34. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 35. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 36. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 37. US & Canada Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 38. US & Canada Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 39. US & Canada Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 40. US & Canada Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 41. US & Canada Plasma Fractionation and Blood Product Revenue Share by Country (2019-2030)
Figure 42. US & Canada Plasma Fractionation and Blood Product Sales Share by Country (2019-2030)
Figure 43. U.S. Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 44. Canada Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 45. Europe Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 46. Europe Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 47. Europe Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 48. Europe Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 49. Europe Plasma Fractionation and Blood Product Revenue Share by Country (2019-2030)
Figure 50. Europe Plasma Fractionation and Blood Product Sales Share by Country (2019-2030)
Figure 51. Germany Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 52. France Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 53. U.K. Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 54. Italy Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 55. Russia Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 56. China Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 57. China Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 58. China Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 59. China Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 60. Asia Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 61. Asia Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 62. Asia Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 63. Asia Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 64. Asia Plasma Fractionation and Blood Product Revenue Share by Region (2019-2030)
Figure 65. Asia Plasma Fractionation and Blood Product Sales Share by Region (2019-2030)
Figure 66. Japan Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 67. South Korea Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 68. China Taiwan Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 69. Southeast Asia Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 70. India Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue Market Share by Type (2019-2030)
Figure 73. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue Market Share by Application (2019-2030)
Figure 75. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Revenue Share by Country (2019-2030)
Figure 76. Middle East, Africa and Latin America Plasma Fractionation and Blood Product Sales Share by Country (2019-2030)
Figure 77. Brazil Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 78. Mexico Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 79. Turkey Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 80. Israel Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 81. GCC Countries Plasma Fractionation and Blood Product Revenue (2019-2030) & (US$ Million)
Figure 82. Plasma Fractionation and Blood Product Value Chain
Figure 83. Plasma Fractionation and Blood Product Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232